Note: Ingredients listed on restricted chemical lists
EC/CAS
201-898-9/89-32-7
Name of the chemical
pyromellitic anhydride
Concentration
≥1-<3%
EC/CAS
1333-86-4
Name of the chemical
carbon black
Concentration
N/A
General Information
Revision date
2022-07-25
Product name
Filament Spectrum Industrial PET CF15
1.2.1 Relevant identified uses
filament used in 3D printers
supplier name
Spectrum Group Sp. z o.o
Emergency telephone
112
Icons in SDS
Company Information
company name
Spectrum Group Sp. z o.o
e-mail address of the competent person responsible for the Safety Data Sheet
office@spectrumfilaments.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H319, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
2.1 Classification of the substance or mixture
Skin Sens. 1 H317, Eye Irrit. 2 H319, Resp. Sens. 1 H334 May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled.
2.2 Label elements
Hazard pictograms and signal words DANGER Dangerous components placed on the label
Contains
1,2,4,5-benzenetetracarboxylic 1,2:4,5-dianhydride.
Hazard statements
H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 Avoid breathing mist/vapours/spray. P280 Wear protective gloves/eye protection/face protection. P284 In case of inadequate ventilation wear respiratory protection. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P342+P311 If experiencing respiratory symptoms: Call a POISON CENTER/doctor. P501 Dispose of contents / container to properly labeled waste containers in accordance with national regulations. p. 1/8
2.3 Other hazards
The substances contained in the product do not meet criteria for PBT or vPvB in accordance with Annex XIII of REACH Regulation. The product does not contain substances included in the list established in accordance with Article 59 (1) for having endocrine disrupting properties, or substances identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 (3) or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0.1 % by weight. Section 3: Composition/inform ation on ingr edie nts
